On the other hand, prion protein has been reported to be involved in neurodegenerative diseases by binding a wide range of β-sheet-rich oligomers, for example, amyloid-β, α-synuclein oligomers and tau aggregates. Here, MAPT is linked to neurodegenerative disease.